MedPath

CARNITOR

CARNITOR (levocarnitine) Tablets (330 mg)

Approved
Approval ID

d2133bc3-9c15-48bd-8b16-b8995a6a14cd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 21, 2023

Manufacturers
FDA

Leadiant Biosciences, Inc.

DUNS: 068301431

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levocarnitine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54482-144
Application NumberNDA018948
Product Classification
M
Marketing Category
C73594
G
Generic Name
levocarnitine
Product Specifications
Route of AdministrationORAL
Effective DateNovember 21, 2023
FDA Product Classification

INGREDIENTS (4)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
LEVOCARNITINEActive
Quantity: 330 mg in 1 1
Code: 0G389FZZ9M
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CARNITOR - FDA Drug Approval Details